Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE

Medifast to Pay Penalty as Part of SEC Settlement

By Pharmaceutical Processing | September 20, 2013

OWINGS MILLS, Md. (AP) — Weight-loss company Medifast will pay a $200,000 civil penalty as part of a settlement with the Securities and Exchange Commission tied to the restatement of certain financial results from 2006 through 2009.

The SEC, when deciding whether to accept the settlement, looked at actions Medifast had taken to remediate concerns. Those actions included hiring additional executive management and accounting personnel for the Owings Mills, Md., company and improving its internal controls.

Medifast Inc. said that it did not admit or deny the SEC’s findings.

In September 2012, a subsidiary of Medifast agreed to pay a $3.7 million civil penalty to settle charges that it violated a previous federal order by making unsupported claims about its weight-loss products. The Federal Trade Commission charged that claims made by Jason Pharmaceuticals Inc. in its ads for meal replacement products violated a 1992 FTC settlement order.

Medifast’s stock fell 54 cents, or 2 percent, to $26.44 in midday trading on Thursday. Over the past year, the stock has traded in a range of $21.75 to $33.29.

Related Articles Read More >

GSK
GSK invests another $800M in Pennsylvania site expansions
This is a BD image of its major IV catheters manufacturing facility in Sandy, Utah, which the company said produces billions of molded components each year.
BD to invest billions in U.S. manufacturing
Diverse factory workers in yellow PPE suits checking production data with clipboard in modern industrial facility, Quality control inspector wearing masks and hairnets working in food or pharma plant
ISO 9001, 14001 and 45001 revisions: What changes and when to start
Artis BioSolutions announces new center of excellence in Spain
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2026 Arrowfly LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Arrowfly
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertisers
    • Advertise
    • PR Submissions
    • Eblast Submissions
  • SUBSCRIBE